109 related articles for article (PubMed ID: 24403445)
1. Wilms' tumor 1 is involved in tumorigenicity of glioblastoma by regulating cell proliferation and apoptosis.
Kijima N; Hosen N; Kagawa N; Hashimoto N; Kinoshita M; Oji Y; Sugiyama H; Yoshimine T
Anticancer Res; 2014 Jan; 34(1):61-7. PubMed ID: 24403445
[TBL] [Abstract][Full Text] [Related]
2. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
[TBL] [Abstract][Full Text] [Related]
3. Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells.
Clark AJ; Ware JL; Chen MY; Graf MR; Van Meter TE; Dos Santos WG; Fillmore HL; Broaddus WC
J Neurosurg; 2010 Jan; 112(1):18-25. PubMed ID: 19392599
[TBL] [Abstract][Full Text] [Related]
4. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
5. The Wilms' tumor suppressor WT1 enhances CD95L expression and promotes activation-induced cell death in leukemic T cells.
Bourkoula K; Englert C; Giaisi M; Köhler R; Krammer PH; Li-Weber M
Int J Cancer; 2014 Jan; 134(2):291-300. PubMed ID: 23832418
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor 1 gene expression in hepatocellular carcinoma promotes cell dedifferentiation and resistance to chemotherapy.
Perugorria MJ; Castillo J; Latasa MU; Goñi S; Segura V; Sangro B; Prieto J; Avila MA; Berasain C
Cancer Res; 2009 Feb; 69(4):1358-67. PubMed ID: 19190340
[TBL] [Abstract][Full Text] [Related]
7. RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line.
Zamora-Avila DE; Franco-Molina MA; Trejo-Avila LM; Rodríguez-Padilla C; Reséndez-Pérez D; Zapata-Benavides P
Melanoma Res; 2007 Dec; 17(6):341-8. PubMed ID: 17992115
[TBL] [Abstract][Full Text] [Related]
8. WT1 and BCR-ABL specific small interfering RNA have additive effects in the induction of apoptosis in leukemic cells.
Elmaagacli AH; Koldehoff M; Peceny R; Klein-Hitpass L; Ottinger H; Beelen DW; Opalka B
Haematologica; 2005 Mar; 90(3):326-34. PubMed ID: 15749664
[TBL] [Abstract][Full Text] [Related]
9. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
Smith SI; Down M; Boyd AW; Li CL
Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
[TBL] [Abstract][Full Text] [Related]
10. Wilms' tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells.
Glienke W; Maute L; Wicht J; Bergmann L
Eur J Cancer; 2009 Mar; 45(5):874-80. PubMed ID: 19196508
[TBL] [Abstract][Full Text] [Related]
11. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
12. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
13. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak.
Morrison DJ; English MA; Licht JD
Cancer Res; 2005 Sep; 65(18):8174-82. PubMed ID: 16166292
[TBL] [Abstract][Full Text] [Related]
14. Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
Vidovic K; Ullmark T; Rosberg B; Lennartsson A; Olofsson T; Nilsson B; Gullberg U
Leuk Res; 2013 Oct; 37(10):1341-9. PubMed ID: 23871158
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor protein Wt1 is an activator of the anti-Müllerian hormone receptor gene Amhr2.
Klattig J; Sierig R; Kruspe D; Besenbeck B; Englert C
Mol Cell Biol; 2007 Jun; 27(12):4355-64. PubMed ID: 17420277
[TBL] [Abstract][Full Text] [Related]
16. Wilms' tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repression.
Chen MY; Clark AJ; Chan DC; Ware JL; Holt SE; Chidambaram A; Fillmore HL; Broaddus WC
J Neurooncol; 2011 May; 103(1):87-102. PubMed ID: 20820871
[TBL] [Abstract][Full Text] [Related]
17. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.
Iwami K; Natsume A; Ohno M; Ikeda H; Mineno J; Nukaya I; Okamoto S; Fujiwara H; Yasukawa M; Shiku H; Wakabayashi T
Neuro Oncol; 2013 Jun; 15(6):747-58. PubMed ID: 23460320
[TBL] [Abstract][Full Text] [Related]
19. Identification of a Novel C-Terminal Truncated WT1 Isoform with Antagonistic Effects against Major WT1 Isoforms.
Tatsumi N; Hojo N; Sakamoto H; Inaba R; Moriguchi N; Matsuno K; Fukuda M; Matsumura A; Hayashi S; Morimoto S; Nakata J; Fujiki F; Nishida S; Nakajima H; Tsuboi A; Oka Y; Hosen N; Sugiyama H; Oji Y
PLoS One; 2015; 10(6):e0130578. PubMed ID: 26090994
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
